Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Non-cash Items (2016 - 2018)

Amicus Therapeutics filings provide 7 years of Non-cash Items readings, the most recent being $374444.0 for Q1 2018.

  • On a quarterly basis, Non-cash Items rose 1334.65% to $374444.0 in Q1 2018 year-over-year; TTM through Mar 2018 was $374444.0, a 1334.65% increase, with the full-year FY2017 number at $8.0 million, up 90.13% from a year prior.
  • Non-cash Items hit $374444.0 in Q1 2018 for Amicus Therapeutics, down from $8.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $34.7 million in Q2 2017 to a low of $24900.0 in Q3 2016.
  • Median Non-cash Items over the past 5 years was $5.4 million (2014), compared with a mean of $8.1 million.
  • Biggest five-year swings in Non-cash Items: surged 7811.78% in 2016 and later tumbled 99.92% in 2017.
  • Amicus Therapeutics' Non-cash Items stood at $1.1 million in 2014, then soared by 407.47% to $5.6 million in 2015, then decreased by 24.76% to $4.2 million in 2016, then skyrocketed by 90.13% to $8.0 million in 2017, then plummeted by 95.31% to $374444.0 in 2018.
  • The last three reported values for Non-cash Items were $374444.0 (Q1 2018), $8.0 million (Q4 2017), and $802826.0 (Q3 2017) per Business Quant data.